Oncology

  • 8 July 2019
    News

    Eisai forms PROTACs research collaboration

    Eisai has formed a research collaboration to support oncology drug discovery using proteolysis targeting chimeras (PROTAC), which comprise two covalently linked protein-binding molecules.

  • 1 July 2019
    News

    Imbruvica receives positive opinion from CHMP

    The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the existing marketing authorisation (MA) for Janssen’s Imbruvica (ibrutinib) to include chronic lymphocytic leukaemia (CLL)...

Close
Close
Close

Go Top